The role of mitochondrial DNA damage and repair in the resistance of BCR/ABL-expressing cells to tyrosine kinase inhibitors. [electronic resource]
Producer: 20140318Description: 16348-64 p. digitalISSN:- 1422-0067
- Antineoplastic Agents -- pharmacology
- Apoptosis
- Benzamides -- pharmacology
- DNA Damage
- DNA Repair
- DNA, Mitochondrial -- genetics
- Drug Resistance, Neoplasm
- Fusion Proteins, bcr-abl -- metabolism
- Genome, Mitochondrial
- Humans
- Imatinib Mesylate
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Piperazines -- pharmacology
- Protein Kinase Inhibitors -- pharmacology
- Pyrimidines -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.